|
Immunotherapy
Citations 251-260 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Rituximab antiproliferative effect in B-lymphoma cells is associated with acid-sphingomyelinase activation in raft microdomains
- Christine Bezombes, Solène Grazide, Céline Garret, Claire Fabre, Anne Quillet-Mary, Sabina Müller, Jean-Pierre Jaffrézou, and Guy Laurent
Blood 2004; 104: 1166-1173.
[Abstract]
[Full text]
[PDF]
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
- Vincent T. Ho, David Zahrieh, Ephraim Hochberg, Eileen Micale, Jesse Levin, Carol Reynolds, Steve Steckel, Corey Cutler, David C. Fisher, Stephanie J. Lee, Edwin P. Alyea, Jerome Ritz, Robert J. Soiffer, and Joseph H. Antin
Blood 2004; 104: 1224-1226.
[Abstract]
[Full text]
[PDF]
Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma
- David A. Rizzieri, Gamal Akabani, Michael R. Zalutsky, R. Edward Coleman, Scott D. Metzler, James E. Bowsher, Bonnie Toaso, Elizabeth Anderson, Anand Lagoo, Steve Clayton, Charles N. Pegram, Joseph O. Moore, Jon P. Gockerman, Carlos DeCastro, Cristina Gasparetto, Nelson J. Chao, and Darell D. Bigner
Blood 2004; 104: 642-648.
[Abstract]
[Full text]
[PDF]
CD40 activation of BCP-ALL cells generates IL-10–producing, IL-12–defective APCs that induce allogeneic T-cell anergy
- Giovanna D'Amico, Marisa Vulcano, Cristina Bugarin, Giancarlo Bianchi, Gisella Pirovano, Martin Bonamino, Virna Marin, Paola Allavena, Ettore Biagi, and Andrea Biondi
Blood 2004; 104: 744-751.
[Abstract]
[Full text]
[PDF]
Germ line tumor-associated immunoglobulin VH region peptides provoke a tumor-specific immune response without altering the response potential of normal B cells
- Qiang Lou, Raymond J. Kelleher, Jr, Alessandro Sette, Jenni Loyall, Scott Southwood, Richard B. Bankert, and Steven H. Bernstein
Blood 2004; 104: 752-759.
[Abstract]
[Full text]
[PDF]
Cytolytic activity and regulatory functions of inhibitory NK cell receptor–expressing T cells expanded from granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cells
- Junji Tanaka, Tomomi Toubai, Yutaka Tsutsumi, Yoko Miura, Naoko Kato, Shintarou Umehara, Kaoru Kahata, Akio Mori, Nobuyasu Toyoshima, Shuichi Ota, Takahiko Kobayashi, Masanobu Kobayashi, Masaharu Kasai, Masahiro Asaka, and Masahiro Imamura
Blood 2004; 104: 768-774.
[Abstract]
[Full text]
[PDF]
Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells
- Zhongde Wang, Corinna La Rosa, Shahram Mekhoubad, Simon F. Lacey, Maria C. Villacres, Susan Markel, Jeff Longmate, Joshua D. I. Ellenhorn, Robert F. Siliciano, Christopher Buck, William J. Britt, and Don J. Diamond
Blood 2004; 104: 847-856.
[Abstract]
[Full text]
[PDF]
Large-scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells
- Petra Hoffmann, Ruediger Eder, Leoni A. Kunz-Schughart, Reinhard Andreesen, and Matthias Edinger
Blood 2004; 104: 895-903.
[Abstract]
[Full text]
[PDF]
Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect
- Angela Gismondi, Loredana Cifaldi, Cinzia Mazza, Silvia Giliani, Silvia Parolini, Stefania Morrone, Jordan Jacobelli, Elisabetta Bandiera, Luigi Notarangelo, and Angela Santoni
Blood 2004; 104: 436-443.
[Abstract]
[Full text]
[PDF]
In vitro–expanded human CD4+CD25+ T-regulatory cells can markedly inhibit allogeneic dendritic cell–stimulated MLR cultures
- Wayne R. Godfrey, Ying G. Ge, Darrin J. Spoden, Bruce L. Levine, Carl H. June, Bruce R. Blazar, and Stephen B. Porter
Blood 2004; 104: 453-461.
[Abstract]
[Full text]
[PDF]
|
|
